paclitaxel has been researched along with Colitis, Ulcerative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellanger, C; Classe, M; Even, C; Garcia, G; Saleh, K | 1 |
| Carneiro, F; Lima, J; Lopes, JM; Magro, F; Pereira, P; Saraiva, A; Sarmento, C; Tavarela-Veloso, F; Teixeira, A | 1 |
2 other study(ies) available for paclitaxel and Colitis, Ulcerative
| Article | Year |
|---|---|
Complete response upon salvage chemotherapy after anti-PD1 failure: Watch and wait.
Topics: Adult; Antineoplastic Agents, Immunological; Colitis, Ulcerative; Hashimoto Disease; Humans; Immune Checkpoint Inhibitors; Male; Nivolumab; Paclitaxel; Programmed Cell Death 1 Receptor; Remission Induction; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tongue Neoplasms; Treatment Failure | 2021 |
Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colitis, Ulcerative; Colon; Constriction, Pathologic; Endoscopy, Gastrointestinal; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Paclitaxel; Peritoneal Neoplasms | 2005 |